PERTH, Australia, 27th November 2017: Phylogica Limited (ASX:PYC) (Phylogica or the Company), provides the Chairman’s Address from the 2017 Annual General Meeting
Good afternoon everyone, on behalf of myself and our Board of Directors here today, I would like to welcome you to Phylogica’s 2017 AGM – we appreciate you taking the time to attend. It has been a year of transformative change for Phylogica, and we believe our work over the last 12 months has put your company in a much stronger position to advance our unique platform technology into meaningful commercial applications.
A key objective during the year was refreshing our executive team to ensure that the skills and capabilities which served us so well in R&D/ discovery are complemented with pharma, commercial and strategic capability.
For further information please download PDF attached:
Download this document